2025
SJR Q1
JCR Q1 · 5,2
16 matched articles
SCIE
Journal detail
Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
034062452567689X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,584
- Quartile Q1
- H-Index 217
- Cites/doc 3,9
- Docs (3y) 514
- Cites (3y) 2.078
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 4,5
- JCI 1,19
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Hematology Q1
Areas
- Medicine
WoS categories
- Hematology | Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,584 | 5,2 | 4,5 | 1,19 | Q1 | 217 |
| 2024 | Q1 | Q1 | 1,436 | 4,3 | 4,2 | 1,14 | Q1 | 211 |
| 2023 | Q1 | Q1 | 1,248 | 5 | 4,4 | 1,1 | Q1 | 211 |
| 2022 | Q1 | Q1 | 1,565 | 6,7 | 5,2 | 1,1 | Q1 | 211 |
| 2021 | Q1 | Q1 | 1,745 | 6,8 | 5,8 | 1,09 | Q1 | 211 |
| 2020 | Q1 | Q1 | 1,97 | 5,7 | 5,4 | 1,21 | Q1 | 211 |
| 2019 | Q1 | Q1 | 1,798 | 4,4 | 4,1 | 1,19 | Q1 | 211 |
| 2018 | — | Q1 | — | 4,7 | 4,5 | 1,27 | Q1 | — |
| 2017 | Q1 | Q1 | 2,074 | 5 | 4,4 | 1,25 | Q1 | 211 |
| 2016 | Q1 | Q1 | 2,148 | 5,6 | 5 | — | — | 211 |
| 2015 | Q1 | Q1 | 2,113 | 5,3 | 4,8 | — | — | 211 |
| 2014 | Q1 | Q1 | 1,85 | 5 | 4,5 | — | — | 211 |
| 2013 | Q1 | Q1 | 2,386 | 5,8 | 4,9 | — | — | 211 |
| 2012 | Q1 | Q1 | 2,506 | 6,1 | 4,8 | — | — | 211 |
| 2011 | Q1 | Q1 | 2,071 | 5 | 4,2 | — | — | 211 |
| 2010 | Q1 | Q1 | 1,857 | 4,7 | 3,9 | — | — | 211 |
| 2009 | — | Q1 | — | 4,5 | 3,6 | — | — | — |
| 2008 | — | Q1 | — | 3,8 | 3,6 | — | — | — |
| 2007 | — | Q2 | — | 3,5 | 3,4 | — | — | — |
| 2006 | — | Q2 | — | 2,8 | — | — | — | — |
| 2005 | — | Q2 | — | 3,1 | — | — | — | — |
| 2004 | — | Q1 | — | 3,4 | — | — | — | — |
| 2003 | — | Q1 | — | 5 | — | — | — | — |
| 2002 | — | Q1 | — | 4,4 | — | — | — | — |
| 2001 | — | Q1 | — | 4,9 | — | — | — | — |
| 2000 | — | Q1 | — | 4,4 | — | — | — | — |
| 1999 | — | Q1 | — | 5 | — | — | — | — |
| 1998 | — | Q1 | — | 3,7 | — | — | — | — |
| 1997 | — | Q1 | — | 4,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | HEMATOLOGY | SCIE | Q1 | Q1 | 16/103 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 17/100 |
| 2024 | HEMATOLOGY | SCIE | Q1 | Q1 | 20/99 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 19/98 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q1 | 18/97 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 13/96 |
| 2022 | HEMATOLOGY | SCIE | Q1 | Q1 | 16/79 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 10/68 |
| 2021 | HEMATOLOGY | SCIE | Q1 | Q1 | 18/78 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 12/67 |
| 2020 | HEMATOLOGY | SCIE | Q1 | Q1 | 19/76 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 10/65 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 17/76 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 11/65 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 15/73 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 9/65 |
| 2017 | HEMATOLOGY | SCIE | Q1 | Q1 | 13/71 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 6/65 |
| 2016 | HEMATOLOGY | SCIE | Q1 | — | 11/70 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/63 |
| 2015 | HEMATOLOGY | SCIE | Q1 | — | 11/70 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 8/63 |
| 2014 | HEMATOLOGY | SCIE | Q1 | — | 10/68 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 8/60 |
| 2013 | HEMATOLOGY | SCIE | Q1 | — | 6/68 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/65 |
| 2012 | HEMATOLOGY | SCIE | Q1 | — | 6/67 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/68 |
| 2011 | HEMATOLOGY | SCIE | Q1 | — | 10/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 9/68 |
| 2010 | HEMATOLOGY | SCIE | Q1 | — | 13/66 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 9/68 |
| 2009 | HEMATOLOGY | SCIE | Q1 | — | 14/61 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 11/61 |
| 2008 | HEMATOLOGY | SCIE | Q1 | — | 15/62 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 12/56 |
| 2007 | HEMATOLOGY | SCIE | Q2 | — | 18/63 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 14/54 |
| 2006 | HEMATOLOGY | SCIE | Q2 | — | 23/61 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 19/52 |
| 2005 | HEMATOLOGY | SCIE | Q2 | — | 21/60 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/51 |
| 2004 | HEMATOLOGY | SCIE | Q1 | — | 15/62 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 12/51 |
| 2003 | HEMATOLOGY | SCIE | Q1 | — | 8/62 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/52 |
| 2002 | HEMATOLOGY | SCIE | Q1 | — | 7/61 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 8/52 |
| 2001 | HEMATOLOGY | SCIE | Q1 | — | 6/59 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 9/50 |
| 2000 | HEMATOLOGY | SCIE | Q1 | — | 6/60 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 7/45 |
| 1999 | HEMATOLOGY | SCIE | Q1 | — | 6/60 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 6/44 |
| 1998 | HEMATOLOGY | SCIE | Q1 | — | 7/59 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 8/39 |
| 1997 | HEMATOLOGY | SCIE | Q1 | — | 6/59 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 5/38 |